Earnings Call · Q3 FY2023·2023-11-02

Q3 23EPS +23.08%·Rev n/aQ2 23EPS +8.33%·Rev n/aQ1 23EPS -7.69%·Rev n/aQ4 22EPS -100.00%*·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal Officer

Carl Hansen — Chief Executive Officer

Andrew Booth — Chief Financial Officer

+7.5%1d on move date+5.6% vs SPY3d+8.6%5d+1.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access